ليست عنوان مقالات لاتين DropletsdepositioninsteampipingconnectingsteamgeneratorandsteamturbineinnuclearplantOriginalResearchArticle Dry densification of carbon nanotube bundles Original Research Article

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

DropletsdepositioninsteampipingconnectingsteamgeneratorandsteamturbineinnuclearplantOriginalResearchArticle

2

Droplet-size dependence of the electron transfer rate across the single-microdroplet/water interface

3

Drop-off during ribosome hopping

4

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

5

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

6

Drop-on-demand drop formation of colloidal suspensions

7

Drop-on-demand printing of cells and materials for designer tissue constructs

8

Dropout Analysis of a National Social Health Insurance Program at Pokhara Metropolitan City, Kaski, Nepal

9

Dropout and early unemployment

10

Dropout from outpatient mental health care: results from the Israel National Health Survey

11

Drop-out from primary schools in tribal India: A case study of the Ho in Parampancho, West Singhbhum

12

Dropout from Rehabilitation and Its Associated Factors in Children with Developmental Disabilities in Tehran Rehabilitation Centers

13

Dropout Prediction and Reduction in Distance Education Courses with the Learning Analytics Multitrail Approach

14

Dropout rate and associated factors in patients with bipolar disorders

15

Dropout rate for intent-to-treat and per protocol analye

16

DROPOUT STEREOTYPE AND TRANSFORMATION OF ORANG KUALA S ORANG ASLI: A REVIEW ON THE ADAPTATION OF THE NEW HUMAN CAPITAL

17

Dropouts and Social Determinants of Health; Policy for the Prevention of School Dropout, Qualitative Study of the Causes and Interventions

18

Drop-outs in tamoxifen prevention trials

19

Drop-outs in tamoxifen prevention trials

20

Dropouts Problem among Karnataka (India) Tribal Children: Where Rubber hits the Road?

21

Dropouts versus completers among chronically depressed outpatients

22

Dropped Gallstones Causing Transdiaphragmatic Migration and Thoracic Empyema

23

Dropped head syndrome after radiotherapy for lymphoma: A report of three cases

24

Dropped Head Syndrome in a Patient with Aeromonas hydrophila-induced Septic Arthritis of the Shoulder

25

Dropped-head and bent-spine syndromes; axial myopathies?

26

Dropping out of mental health treatment among patients with depression and anxiety by type of provider: results of the European Study of the Epidemiology of Mental Disorders

27

Dropping out of school: A review of intervention programs

28

Dropping rates of elaiosome-bearing seeds during transport by ants (Formica polyctena Foerst.): Implications for distance dispersal

29

Dropping the weight stigma: Nostalgia improves attitudes toward persons who are overweight

30

Dropping variables versus use of proxy variables in linear regression

31

Drops deformation and magnetic permeability of a ferrofluid emulsion

32

Drops that pull themselves up

33

Drop-Size Analysis in a Two-Phase Reactive Liquid-Liquid System on a Bubble-Cap Tray

34

Dropstones, pseudoplanktonic forms and deep-water decapod crustaceans within a Lutetian condensed succession of central Istria (Croatia): relation to palaeoenvironmental evolution and palaeogeography

35

Dropstones: their origin and significance

36

Dropstones: their origin and significance: a comment

37

Drop-to-drop microextraction across a supported liquid membrane by an electrical field under stagnant conditions

38

Drop-weight test based identification of elastic half-space model parameters

39

Dropwise condensation from flowing air–steam mixtures: Diffusion resistance assessed by controlled drainage

40

Dropwise condensation heat transfer on ion implanted aluminum surfaces

41

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS

42

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS AN EXPERIMENTAL STUDY OF THE TWO-PHASE FLOW ADJACENT TO A WIRE IN NUCLEATE BOILING UNDER AN ELECTRIC FIELD

43

Dropwise condensation of steam on ion implanted titanium surfaces

44

Dropwise condensation on L-B film surface

45

Dropwise condensation rate of water breath figures on polymer surfaces having similar surface free energies

46

Dropwise cooling: Experimental tests by infrared thermography and numerical simulations

47

Dropwise deposition and wetting of nanoparticle suspensions

48

Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes

49

Drosophila Auditory Organ Genes and Genetic Hearing Defects

50

Drosophila BAP60 is an Essential Component of the Brahma Complex, Required for Gene Activation and Repression

51

Drosophila BTB/POZ Domains of “ttk Group” Can Form Multimers and Selectively Interact with Each Other

52

Drosophila Calmodulin Mutants With Specific Defects in the Musculature or in the Nervous System

53

Drosophila Checkpoint Kinase 2 Couples Centrosome Function and Spindle Assembly to Genomic Integrity

54

Drosophila Clock Can Generate Ectopic Circadian Clocks

55

Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis

56

Drosophila cryb mutation reveals two circadian clocks that drive locomotor rhythm and have different responsiveness to light

57

Drosophila CTCF Is Required for Fab-8 Enhancer Blocking Activity in S2 Cells

58

Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion

59

Drosophila DPM Neurons Form a Delayed and Branch-Specific Memory Trace after Olfactory Classical Conditioning

60

Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity

61

Drosophila Dumbfounded: A Myoblast Attractant Essential for Fusion

62

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

63

Drosophila fasciclinII Is Required for the Formation of Odor Memories and for Normal Sensitivity to Alcohol

64

Drosophila female precopulatory behavior is modulated by ecdysteroids

65

Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function

66

Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling

67

Drosophila genome sequence, a model for the human

68

Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate

69

Drosophila gustatory receptors: from gene identification to functional expression

70

Drosophila immunity: paths and patterns

71

Drosophila immunity: two paths to NF-κB

72

Drosophila male courtship behavior is modulated by ecdysteroids

73

Drosophila males transfer antibacterial proteins from their accessory gland and ejaculatory duct to their mates

74

Drosophila melanogaster and D. simulans rescue strains produce fit offspring, despite divergent centromerespecific histone alleles

75

Drosophila melanogaster as a Model to Study Human Neurodegenerative Diseases

76

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

77

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

78

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

79

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

80

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

81

Drosophila model increases understanding of fragile-X syndrome

82

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

83

Drosophila neural progenitor polarity and asymmetric division

84

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

85

Drosophila p53 Binds a Damage Response Element at the reaper Locus

86

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

87

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

88

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

89

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

90

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

91

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

92

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

93

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

94

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

95

Drosophila still flying high in cancer research

96

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

97

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

98

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

99

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

100

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

101

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

102

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

103

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

104

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

105

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

106

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

107

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

108

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

109

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

110

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

111

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

112

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

113

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

114

Drought and climatic change impact on streamflow in small watersheds Original Research Article

115

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

116

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

117

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

118

Drought and ecosystem carbon cycling

119

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

120

Drought and grazing patch dynamics under different grazing management

121

Drought and malaria retreat in the Sahel, West Africa

122

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

123

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

124

Drought and saving in West Africa: are livestock a buffer stock?

125

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

126

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

127

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

128

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

129

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

130

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

131

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

132

Drought disturbance from climate change: response of United States forests

133

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

134

Drought early warning system in reservoir operation: Theory and practice

135

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

136

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

137

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

138

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

139

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

140

Drought experiments within the Solling roof project

141

Drought Flow from Hillslope

142

Drought Flow from Hillslope

143

Drought forecasting based on the remote sensing data using ARIMA models

144

Drought forecasting using feed-forward recursive neural network

145

Drought forecasting using feed-forward recursive neural network

146

Drought forecasting using the Standardized Precipitation Index

147

Drought frequency analysis using cluster analysis and bivariate probability distribution

148

Drought identification and characterization in Jordan

149

Drought impacts on the water quality of freshwater systems; review and integration

150

Drought in groundwater—drought distribution and performance indicators

151

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

152

Drought is a major yield loss factor for rainfed East African highland banana

153

Drought mitigation using operative indicators in complex water systems

154

Drought modeling – A review

155

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

156

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

157

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

158

Drought monitoring in Iran using the perpendicular drought indices

159

Drought Monitoring in Southern Coasts of Iran

160

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

161

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

162

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

163

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

164

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

165

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

166

Drought planning and water allocation: an assessment of local capacity in Minnesota

167

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

168

Drought probabilities and return period for annual streamflows series

169

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

170

Drought response of two bedding plants

171

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

172

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

173

Drought Risk Assessment in Western Inner-Mongolia

174

Drought Risk Assessment: A Case Study in Punjab, Pakistan

175

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

176

Drought Risk Vulnerability Parameters among Wheat

177

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

178

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

179

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

180

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

181

Drought stress effect on some phonological traits of advanced lines of bread wheat

182

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

183

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

184

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

185

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

186

Drought stress tolerance based on selection indices of resistant crops variety

187

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

188

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

189

Drought Stress: A Review

190

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

191

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

192

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

193

Drought threatened semi-arid ecosystems in the Inner Asia

194

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

195

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

196

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

197

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

198

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

199

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

200

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

201

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

202

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

203

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

204

Drought variability and its climatic implications

205

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

206

Drought vulnerability assessment: The case of wheat farmers in Western Iran

207

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

208

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

209

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

210

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

211

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

212

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

213

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

214

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

215

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

216

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

217

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

218

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

219

Drought-induced variations of water relations parameters in Olea europaea

220

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

221

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

222

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

223

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

224

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

225

Droughts as random events in the Maya lowlands

226

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

227

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

228

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

229

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

230

Drowning by numbers and itʹs

231

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

232

Drowning in information, but thirsty for knowledge

233

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

234

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

235

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

236

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

237

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

238

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

239

Drowsiness Detection – A Visual System for Driver Support

240

Drs. Landon and Kahn respond:

241

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

242

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

243

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

244

Druen complement component C3a and C5a promote choroidal neovacularization

245

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

246

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

247

Drug abuse among nurses: A neglected challenge

248

Drug Abuse among University Students of Rafsanjan, Iran

249

Drug abuse and aggression between intimate partners: A meta-analytic review

250

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

251

Drug abuse in older US adults worries experts

252

Drug Abuse in Prishtina Region

253

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

254

Drug Abuse Research Trend Investigation with Text Mining

255

Drug abuse toll uncovered in Kenya

256

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

257

Drug abuse: A significant variable in schizophrenia research

258

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

259

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

260

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

261

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

262

Drug addiction and HIV infection on rise in Tajikistan

263

Drug addiction and the economic rationalization of gun control

264

Drug addiction and the economic rationalization of gun control

265

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

266

Drug addiction as drive satisfaction ("antidrive") dysfunction

267

Drug Addiction as Risk for Suicide Attempts

268

Drug addiction in Gaza and the illicit trafficking of tramadol

269

Drug addiction: the neurobiology of disrupted self-control

270

Drug administration to poultry

271

Drug adverse events and drop-out risk: A clinical case

272

Drug advertisements and prescribing

273

Drug advertisements and prescribing

274

Drug advertisements in less-developed countries

275

Drug advertisements in medical journals

276

Drug advertisements that go straight to the hippocampus

277

Drug advertising in medical journals

278

Drug advertising in medical journals

279

Drug advertising in medical journals

280

Drug advertising in medical journals

281

Drug advertising in medical journals

282

Drug advertising in medical journals

283

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

284

Drug allergic reactions and distress vulnerability

285

Drug allergies among patients with borderline personality symptomatology

286

287

Drug allergy transmitted by passionate kissing

288

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

289

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

290

Drug and alcohol use among drivers admitted to a Level-1 trauma center

291

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

292

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

293

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

294

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

295

Drug and DNA delivery to mitochondria

296

Drug and DNA delivery to mitochondria

297

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

298

Drug and gene delivery to mucosal tissues: the mucus barrier

299

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

300

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

301

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

302

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

303

Drug bulletins: independent information for global use

304

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

305

Drug calculation skills — Are we running scared?

306

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

307

Drug choices in the treatment of atrial fibrillation

308

Drug classification systems: Applications and characteristics

309

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

310

Drug combinations best in acute asthma attacks

311

Drug combinations for HD tested in Drosophila

312

Drug combinations for malaria: time to ACT?

313

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

314

Drug companies can broadcast across Europe

315

Drug companies caught again for fixing worldwide vitamin prices

316

Drug company sued over research trial in Nigeria

317

Drug company trials come under increasing scrutiny

318

Drug comparison and categorizing regarded with human serum albumin

319

Drug complications poorly recorded in medical charts

320

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

321

Drug courts: A bridge between criminal justice and health services

322

Drug Craving Terminology among Opiate Dependents;

323

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

324

Drug crops threaten Colombian birds

325

326

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

327

Drug delivery applications of supercritical fluid technology

328

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

329

Drug delivery devices based on macroporous silica spheres

330

Drug Delivery for Brains and Central Nervous System

331

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

332

Drug delivery from gold and titanium surfaces using self-assembled monolayers

333

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

334

Drug delivery in degenerative joint disease

335

Drug delivery in degenerative joint disease: Where we are and where to go?

336

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

337

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

338

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

339

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

340

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

341

Drug delivery strategies in the therapy of inflammatory bowel disease

342

Drug delivery strategies to treat age-related macular degeneration

343

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

344

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

345

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

346

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

347

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

348

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

349

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

350

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

351

Drug delivery to mitochondria: the key to mitochondrial medicine

352

Drug delivery to mitochondria: the key to mitochondrial medicine

353

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

354

Drug delivery to solid tumors by elastin-like polypeptides

355

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

356

Drug delivery to the brain-just a sniff away

357

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

358

Drug delivery to the posterior segments of the eye

359

Drug delivery vehicles on a nano-engineering perspective

360

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

361

Drug Dependency and Womenʹs Health

362

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

363

Drug deregulation in Japan likely by 1998

364

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

365

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

366

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

367

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

368

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

369

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

370

Drug detection by tandem mass spectrometry on the basis of adduct formation

371

Drug development and clinical research in the UK

372

Drug development for neglected diseases

373

Drug development for neglected diseases: a deficient market and a public-health policy failure

374

Drug development for tuberculosis: the missing ingredient

375

Drug development output: what proportion for tropical diseases?

376

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

377

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

378

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

379

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

380

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

381

Drug discovery and chemokine receptor antagonists: eppur si muove!

382

Drug Discovery and Delivery in the 21st Century

383

Drug Discovery and Evaluation

384

Drug discovery and sea hares: bigger is better

385

Drug Discovery in the Clouds

386

Drug discovery in the new millennium: the pivotal role of biotechnology

387

Drug discovery in the wake of genomics

388

Drug discovery of the future: the implications of the human genome project

389

Drug discovery through stem cell-based organoid models

390

Drug dispensing systems in Gaza hospitals: a comparative study

391

Drug disposition in obesity and protein-energy malnutrition

392

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

393

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

394

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

395

Drug efflux transporters in the CNS

396

Drug elimination in chronic liver diseases

397

Drug eluting stent

398

Drug ELuting Stent Complications

399

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

400

Drug Eluting Stent Restenosis

401

Drug eluting stents

402

Drug Eluting Stents Comparisons

403

Drug Eluting Stents I

404

Drug Eluting Stents II

405

Drug Eluting Stents in Diabetic Patients

406

Drug eluting stents may not be the answer for myocardial bridges

407

Drug eluting stents: Comparative results

408

Drug eluting stents: Current status and new developments

409

Drug eluting stents: In stent restenosis

410

Drug eluting stents: Long term results

411

Drug eradicates Chagasʹ parasite in mice

412

Drug evaluations using a novel microphysiometer based on cell-based biosensors

413

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

414

Drug excretion into breast milk—Overview

415

Drug exposed infants in the social welfare system and Juvenile Court

416

Drug firm buys up chain of US cancer clinics

417

Drug firm compensates patients for suspected hepatitis B vaccine failure

418

Drug firm support of American Medical Association ethics effort draws fire

419

Drug firm withdraws statin from the market

420

Drug firms lose patent rights lawsuit against South Africaʹs government

421

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

422

Drug firms take South Africaʹs government to court

423

Drug firms under fire over anti-competition in USA

424

Drug for impotence breaks prescription records

425

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

426

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

427

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

428

Drug identification performance on the basis of observable signs and symptoms

429

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

430

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

431

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

432

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

433

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

434

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

435

Drug Induced Ectropion: a Systematic Review

436

Drug Induced Gingival Overgrowth and Its Management

437

Drug induced hepatitis among Iranian patients suffering from tuberculosis

438

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

439

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

440

Drug industry lobbies against European research-data directive

441

Drug Information Resources at Private Community Pharmacies in Kuwait

442

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

443

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

444

Drug injection cessation among HIV-infected injecting drug users

445

Drug interaction between rifampicin and sirolimus in transplant patients

446

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

447

Drug interaction of St Johnʹs wort with ciclosporin

448

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

449

Drug interactions and anti-infective therapies

450

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

451

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

452

Drug interactions in cancer patients: A hidden risk?

453

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

454

Drug Interactions of Green Tea

455

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

456

Drug Interactions of Metformin Involving Drug Transporter Proteins

457

Drug Interactions of Psychiatric and COVID-19 Medications

458

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

459

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

460

Drug interactions with the taxanes: clinical implications

461

Drug interactions with zileuton

462

Drug interactions with zileuton

463

Drug interactions—fact or fiction?

464

Drug intervention trials in sepsis

465

Drug intervention trials in sepsis: divergent results

466

Drug kinetics and drug resistance in optimal chemotherapy

467

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

468

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

469

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

470

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

471

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

472

Drug Management in Crisis and Disaster in Selected Countries and Iran

473

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

474

Drug may avoid need for parathyroidectomy

475

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

476

Drug metabolism and drug interactions in the elderly

477

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

478

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

479

Drug nanocarrier agents based on starch-g-amino acids

480

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

481

Drug partition chromatography on immobilized porcine intestinal brush border membranes

482

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

483

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

484

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

485

Drug policy in China: pharmaceutical distribution in rural areas

486

Drug policy: should the law take a back seat?

487

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

488

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

489

Drug Prescription Pattern in a Nigerian Tertiary Hospital

490

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

491

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

492

Drug prevents SIV infection

493

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

494

Drug problem recognition among african american drug-using arrestees

495

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

496

Drug quality, a contributor to drug resistance?

497

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

498

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

499

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

500

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

501

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

502

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

503

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

504

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

505

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

506

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

507

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

508

Drug referendum backs Swiss government

509

Drug reimportation: sitting in the middle

510

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

511

Drug related deaths—causes and numbers

512

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

513

Drug release behavior of beads and microgranules of chitosan

514

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

515

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

516

Drug release characteristics of phase separation pHEMA sponge materials

517

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

518

Drug release from a porous ion-exchange membrane in vitro

519

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

520

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

521

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

522

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

523

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

524

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

525

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

526

Drug release kinetics and biological properties of a novel local drugcarrier system

527

Drug release kinetics from monolayer films of glucose-sensitive microgel

528

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

529

Drug release rate and kinetic investigation of composite polymeric nanofibers

530

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

531

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

532

Drug release through liposome pores

533

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

534

Drug Repositioning: A Review

535

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

536

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

537

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

538

Drug resistance among acid-fast bacilli

539

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

540

Drug resistance and apoptosis-inducing strategies in cancer therapy

541

Drug resistance and influenza pandemics

542

Drug resistance and influenza pandemics

543

Drug resistance and influenza pandemics

544

Drug resistance and influenza pandemics

545

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

546

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

547

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

548

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

549

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

550

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

551

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

552

Drug resistance in epilepsy: not futile, but complex?

553

Drug Resistance in Equine Parasites: An Emerging Global Problem

554

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

555

Drug resistance in malaria: Its population biology and implications for control

556

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

557

Drug resistance in tuberculosis—a reinfection model

558

Drug resistance models for malaria

559

Drug Resistance of Acinetobacter in Selected Hospitals

560

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

561

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

562

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

563

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

564

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

565

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

566

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

567

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

568

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

569

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

570

Drug resistance patterns in pulmonary tuberculosis

571

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

572

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

573

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

574

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

575

Drug Resistance: A Periplasmic Ménage à Trois

576

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

577

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

578

Drug resistant Plasmodium falciparum in an area of seasonal transmission

579

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

580

Drug Resistant Tuberculosis: Gold, Glitter and Hope

581

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

582

Drug Safety Crises Management in Pharmacovigilance

583

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

584

585

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

586

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

587

Drug shows potential for treatment of Huntingtonʹs disease

588

Drug shows promise for treatment of Alzheimerʹs disease

589

Drug solubility: how to measure it, how to improve it

590

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

591

Drug subsidy could help Tanzania tackle malaria

592

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

593

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

594

Drug Switching, a Creative Approach to Leukemia Therapy

595

Drug target inference through pathway analysis of genomics data

596

Drug targeting of airway surface liquid: A pharmacological MRI approach

597

Drug targeting to choroidal neovascularization

598

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

599

Drug targeting to the kidney

600

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

601

Drug testing litigation: Trends and outcomes

602

Drug testing sworn law enforcement officers: One agencyʹs experience

603

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

604

605

606

Drug therapy and microvolt T-wave alternans testing

607

Drug therapy and microvolt T-wave alternans testing

608

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

609

Drug therapy for coronary heart disease: the Sheffield table

610

Drug therapy for coronary heart disease: the Sheffield table

611

Drug therapy for coronary heart disease: the Sheffield table

612

Drug therapy for coronary heart disease: the Sheffield table

613

Drug therapy for coronary heart disease: the Sheffield table

614

Drug therapy for coronary heart disease: the Sheffield table

615

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

616

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

617

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

618

Drug therapy for management of obesity

619

Drug therapy for management of obesity

620

Drug Therapy for Small Abdominal Aortic Aneurysm

621

Drug therapy for treatment of obesity

622

Drug therapy for urinary incontinence

623

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

624

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

625

Drug therapy in paediatric patients

626

Drug therapy in reproductive endocrinology

627

Drug therapy increases long-term survival in pulmonary hypertension patients

628

Drug therapy of diabetes in the elderly

629

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

630

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

631

Drug Trafficking and Criminal Justice

632

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

633

Drug transfer through mucus

634

Drug transfer through mucus

635

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

636

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

637

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

638

Drug transport proteins in the liver

639

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

640

Drug treatment for bleeding oesophageal varices

641

Drug treatment for Crohnʹs disease

642

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

643

Drug treatment of delirium: Past, present and future

644

Drug treatment of non-variceal upper gastrointestinal bleeding

645

Drug treatment of obesity

646

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

647

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

648

Drug treatment-related factors of inadequate seizure control

649

Drug treatments for obesity

650

Drug treatments for obesity

651

Drug treatments for obesity

652

Drug treatments for obesity – Authorsʹ reply

653

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

654

Drug treatments of levodopa-induced dyskinesias

655

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

656

Drug use and abuse in sport

657

Drug use and drinking among students in 36 countries

658

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

659

Drug use and HIV/ AIDS in Burma

660

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

661

Drug use and the severity of a traffic accident

662

Drug use behaviors among asian drug users in san francisco

663

Drug use behaviour of pregnant women in rural India

664

Drug use during pregnancy

665

Drug use during pregnancy

666

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

667

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

668

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

669

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

670

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

671

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

672

Drug use is associated with elevated food consumption in college students

673

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

674

Drug Use Patterns at Major Rock Concert Events

675

Drug usersʹ access to community-based services

676

Drug usersʹ brains to be removed 2 hours after death

677

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

678

Drug utilisation and self-medication in rural communities in Vietnam

679

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

680

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

681

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

682

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

683

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

684

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

685

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

686

Drug Utilization Evaluation of Colistin: A Retrospective Study

687

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

688

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

689

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

690

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

691

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

692

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

693

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

694

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

695

Drug Utilization Evaluation of Vancomycin in Pediatric Department

696

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

697

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

698

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

699

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

700

Drug with potential to clear amyloid

701

Drug/device combinations for local drug therapies and infection prophylaxis

702

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

703

Drug-company sponsorship and the Declaration of Helsinki

704

Drug-company sponsorship and the Declaration of Helsinki

705

Drug-delivering coronary artery stents: bare metal threatened by extinction?

706

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

707

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

708

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

709

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

710

Drug-drug co-crystals

711

Drug-Drug Interaction Extraction via Convolutional Neural Networks

712

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

713

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

714

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

715

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

716

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

717

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

718

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

719

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

720

Drug-Drug-Induced Akathisia: Two Case Reports

721

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

722

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

723

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

724

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

725

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

726

Drug-eluting bioabsorbable stents – An in vitro study

727

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

728

Drug-eluting stent fracture occurred within 2 days after stent implantation

729

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

730

Drug-Eluting Stent Fracture: Promise and Performance

731

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

732

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

733

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

734

Drug-Eluting Stent Thrombosis: A Pooled Analysis

735

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

736

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

737

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

738

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

739

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

740

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

741

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

742

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

743

Drug-Eluting stents

744

Drug-Eluting Stents “Next Generation” Basic Science Workshop

745

Drug-eluting stents 1— preclinical

746

Drug-eluting stents 2-economics and cost effectiveness

747

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

748

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

749

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

750

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

751

Drug-eluting stents and late stent thrombosis

752

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

753

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

754

Drug-Eluting Stents for Acute Myocardial Infarction

755

Drug-eluting stents for coronary artery disease: A review

756

Drug-Eluting Stents for Critical Limb Ischemia

757

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

758

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

759

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

760

Drug-eluting stents in diabetics & Complex patient groups

761

Drug-Eluting Stents in Heart Transplant Recipients

762

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

763

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

764

Drug-eluting stents in vascular intervention

765

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

766

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

767

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

768

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

769

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

770

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

771

Drug-eluting stents: A multidisciplinary success story

772

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

773

Drug-eluting stents: Beyond the hyperbole

774

Drug-eluting stents: Factors governing local pharmacokinetics

775

Drug-eluting stents: Failures and restenosis

776

Drug-eluting stents: insights into safety and indications

777

Drug-eluting stents: is new necessarily better?

778

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

779

Drug-eluting stents: Lesion subsets

780

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

781

Drug-eluting stents: Miscellaneous

782

Drug-eluting stents: Patient and lesion subsets

783

Drug-eluting stents: Registries and trials

784

Drug-eluting stents: Registries and trials

785

Drug-eluting stents: results, promises and problems

786

Drug-eluting stents: some bare facts

787

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

788

Drug-evaluation harmonisation will lead to fewer animal tests

789

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

790

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

791

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

792

Drugging Drug Resistance

793

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

794

Drugging the Undruggable

795

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

796

Drug-hormone interactions on neurobehavioral responses in human neonates

797

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

798

Drug-induced amnesia impairs implicit relational memory

799

Drug-induced and toxic myopathies

800

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

801

Drug-induced atrial fibrillation Review Article

802

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

803

Drug-induced autoimmunity

804

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

805

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

806

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

807

Drug-induced cholestasis

808

Drug-induced gingival overgrowth and its tentative pharmacotherapy

809

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

810

Drug-induced headaches

811

Drug-induced headaches

812

Drug-induced heart failure

813

drug-induced hemophagocytosis

814

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

815

Drug-induced hyperkalemia

816

Drug-induced hyperkalemia: old culprits and new offenders

817

Drug-induced hyperkalemia: The reply:

818

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

819

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

820

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

821

Drug-Induced Lichen Planus

822

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

823

Drug-induced liver diseases

824

Drug-induced liver injury following positive drug rechallenge

825

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

826

Drug-Induced Lupus Erythematosus

827

Drug-induced lupus erythematosus

828

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

829

Drug-induced myocardial infarction in young patients: Report of two cases

830

Drug-induced Nephrotoxicity and Medicinal Plants

831

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

832

Drug-Induced Pemphigoid:: Bullous and Cicatricial

833

Drug-Induced Pemphigus

834

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

835

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

836

Drug-induced renal disorders

837

Drug-Induced Scleroderma and Sclerodermiform Conditions

838

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

839

Drug-induced systemic lupus erythematosus and TNF-α blockers

840

Drug-induced systemic lupus erythematosus and TNF-α blockers

841

Drug-induced systemic lupus erythematosus and TNF-α blockers

842

Drug-induced systemic lupus erythematosus associated with etanercept therapy

843

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

844

Drug-Induced Toxic Epidermal Necrolysis

845

Drug-induced tremors

846

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

847

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

848

Drug-licensing anomalies and Parkinsonʹs disease

849

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

850

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

851

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

852

Drug-lunch alert

853

Drugmaker seeks permissions to collaborate on Cuban vaccine

854

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

855

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

856

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

857

Drug-related killings: a case of mistaken identity Review Article

858

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

859

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

860

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

861

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

862

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

863

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

864

Drug-resistant enteric fever in the UK

865

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

866

Drug-resistant genotyping in HIV-1 therapy

867

Drug-resistant genotyping in HIV-1 therapy

868

Drug-resistant genotyping in HIV-1 therapy

869

Drug-resistant genotyping in HIV-1 therapy

870

Drug-resistant genotyping in HIV-1 therapy

871

Drug-resistant gonorrhoeae spread in the USA

872

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

873

Drug-resistant Pneumocystis carinii

874

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

875

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

876

Drug-resistant strains of HIV increase sharply in Japan

877

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

878

Drug-resistant tuberculosis

879

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

880

Drug-resistant tuberculosis in Taipei, 1996-1999

881

Drug-resistant tuberculosis: desperate measures?

882

Drugs & devices in brief

883

Drugs against superbugs: private lessons from bacteriophages

884

Drugs and a dark future

885

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

886

Drugs and demons

887

Drugs and mental health

888

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

889

Drugs and nutrition: how side effects can influence nutritional intake

890

Drugs and nutrition: Important drug-nutrient interactions

891

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

892

Drugs and pests: intertemporal production externalities

893

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

894

Drugs and risk-taking in tourism

895

Drugs and the art of Fred Tomaselli

896

Drugs and the immune system: the emerging era of immunopharmacology

897

Drugs deaths drop in Switzerland

898

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

899

Drugs Expiration Date Dilemma!

900

Drugs for Left Ventricular Remodeling in Heart Failure

901

Drugs for obstetric conditions

902

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

903

Drugs for vascular dementia

904

Drugs in Exacerbation and Provocation of Psoriasis

905

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

906

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

907

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

908

Drugs in the Plant

909

Drugs in the postgenomic era

910

Drugs Induced Alzheimer’s Disease in Animal Model

911

Drugs lose out to revascularisation in symptom-free coronary disease

912

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

913

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

914

Drugs of Abuse and Immuno-Modulation

915

Drugs of abuse and reward comparison: a brief review

916

Drugs of abuse and the elicitation of human aggressive behavior

917

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

918

Drugs of abuse in pregnancy

919

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

920

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

921

Drugs Prescribed by Dentists in Fars Province, Iran

922

Drugs solubilization in ascorbyl–decanoate micellar solutions

923

924

Drugs Used in Pregnancy

925

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

926

Drugs, diet and disease

927

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

928

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

929

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

930

Drug-testing practices in US hotels

931

Drug-trial “irregularities” uncovered in Argentina

932

Drug-trial compensation demands in lreland

933

Drug-use behavior and correlates in people with schizophrenia

934

Drug-use initiation and conduct disorder among adolescents in drug treatment

935

Druid wins Baan contract with Weston Aerospace

936

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

937

Drum granulation of NPK fertilizers

938

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

939

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

940

Drum-boiler dynamics

941

Drum-like silencers using magnetic forces in a pressurized cavity

942

943

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

944

Drunk driving and mental disorders

945

Drunk driving and mental disorders

946

Drunk, but not blind: The effects of alcohol intoxication on change blindness

947

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

948

Drushbametrics — My Russian adventures

949

Dry aging of beef in a bag highly permeable to water vapour

950

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

951

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

952

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

953

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

954

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

955

Dry and wet abrasive resistance of Inconel 600 and stellite

956

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

957

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

958

Dry and wet deposition of elements in Hong Kong

959

Dry and wet deposition of mercury near a chlor-alkali plant

960

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

961

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

962

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

963

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

964

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

965

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

966

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

967

Dry atmospheric deposition and diazotrophy as sources of new nitrogen to northwestern Mediterranean oligotrophic surface waters

968

Dry atmospheric deposition rates of metals along a coastal transect in southern California

969

Dry atmospheric fluxes of trace metals (Al, Fe, Mn, Pb, Cd, Zn, Cu) over the Levantine Basin: A refined assessment

970

Dry atmospheric inputs of trace metals at the Mediterranean coast of Israel (SE Mediterranean): sources and fluxes

971

Dry bag isostatic pressing for improved green strength of surrogate nuclear fuel pellets

972

Dry Bean Intake of Women Ages 19-45

973

Dry Bean Production in Zero and Conventional Tillage

974

Dry beneficiation of Slovakian coal

975

Dry beneficiation technology of coal with an air dense-medium fluidized bed

976

Dry boards as load bearing element in the profiled steel sheet dry board floor panel system—structural performance and applications

977

Dry catalyst impregnation in a double cone blender: A computational and experimental analysis

978

Dry catalytic partial oxidation of diesel–fuel distillates into syngas

979

Dry citrate-precursor synthesized nanocrystalline cobalt oxide as highly active catalyst for total oxidation of propane

980

Dry cleaning for metallic contaminants removal as the second cleaning process after the CMP process

981

Dry cleaning of metal surfaces by a vacuum arc

982

Dry climate near the Western Pacific Warm Pool: Pleistocene caliches of the Nansha Islands, South China Sea

983

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

984

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

985

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

986

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

987

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

988

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

989

Dry coating of talc particles with fumed silica: Influence of the silica concentration on the wettability and dispersibility of the composite particles

990

Dry coating polymer powder particles with deagglomerated carbon nanotubes to improve their dispersion in nanocomposites

991

Dry coatings and ecodesign part. 1 — Environmental performances and chemical properties

992

Dry coatings and ecodesign: Part. 2 — Tribological performances

993

Dry cooling towers as condensers for geothermal power plants

994

Dry cooling with night cool storage to enhance solar power plants performance in extreme conditions areas

995

Dry cupping therapy and the wellness management of health travelers

996

Dry cutting performance of partially filtered arc deposited titanium aluminium nitride coatings with various metal nitride base coatings

997

Dry deep drawability of A5052 aluminum alloy sheet with DLC-coating

998

Dry degumming of vegetable oils by membrane filtration Original Research Article

999

Dry dense medium separation of iron ore using a gas–solid fluidized bed

1000

Dry densification of carbon nanotube bundles Original Research Article

بازگشت